Innovative Genetics has secured an investment agreement with Flavocure Biotech Inc., a leader in transforming natural products into new cures for patients.

The company has discovered several promising new drug candidates. In collaboration with some of the most prestigious research institutions in the world, Flavocure is advancing these candidates through clinical research. Preliminary data indicate that Flavocure’s drug candidates possess activity against known driver mutations and targets implicated in cancer.

Caflanone is Flavocure’s lead drug candidate and received FDA Orphan Drug Designation in 2019 for pancreatic cancer. 

Our partnership with Flavocure Biotech Inc. allows us to tap into their expertise in the field of biotechnology, specifically in the development of cancer treatments. Flavocure Biotech Inc. is at the forefront of the industry and has a track record of success in discovering new drug candidates and bringing them to market.

Flavocure Biotech Inc. has a strong pipeline of drug candidates that show promising results in treating cancer. These candidates have been discovered through years of research and development and are being advanced through clinical trials in collaboration with some of the most prestigious research institutions in the world.

Caflanone is Flavocure's lead drug candidate and has been designated as an Orphan Drug by the FDA. This designation is given to drugs that show promise in treating a rare disease, and it is a testament to the potential impact that Caflanone may have on people's lives.

Innovative Genetics is committed to investing in the development of these drug candidates and bringing them to market as quickly as possible. We are fully dedicated to working with Flavocure Biotech Inc. to bring these treatments to patients in need as quickly as possible.

We also believe that this partnership will open new opportunities for us to explore other areas of biotechnology and medical research and development. We are constantly looking for new opportunities to invest in and develop innovative products that will have a positive impact on human health and well-being.